SARS-CoV-2 vaccination: Immunity and disease activity in immune- mediated inflammatory diseases

P.J. van Dam

SARS-CoV-2 vaccination: Immunity and disease activity in immune- mediated inflammatory diseases

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

During the SARS-Cov-2 pandemic, patients with immune-mediated inflammatory diseases (IMIDs) were faced with two pressing questions. Firstly, as these patients often use immunosuppressants, it was not known whether they would build sufficient immunity after a SARS-CoV-2 infection or vaccination. Secondly, IMID patients were concerned that vaccination could

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	Kuijpers, Taco, Supervisor van de Beek, Diederik, Supervisor Eftimov, Filip, Co-supervisor Wieske, Luuk, Co-supervisor Kuijpers, Taco W., Supervisor, External person
Award date	5 Jun 2024
Publication status	Published - 2024

Access to Document

Cite this

@phdthesis{1dd2a5c11cfb4408bb7ad27e4f4a6aef,

title = "SARS-CoV-2 vaccination: Immunity and disease activity in immune- mediated inflammatory diseases",

abstract = "During the SARS-Cov-2 pandemic, patients with immune-mediated inflammatory diseases (IMIDs) were faced with two pressing questions. Firstly, as these patients often use immunosuppressants, it was not known whether they would build sufficient immunity after a SARS-CoV-2 infection or vaccination. Secondly, IMID patients were concerned that vaccination could",

author = "{van Dam}, P.J.",

year = "2024",

language = "English",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - SARS-CoV-2 vaccination

T2 - Immunity and disease activity in immune- mediated inflammatory diseases

AU - van Dam, P.J.

PY - 2024

Y1 - 2024

N2 - During the SARS-Cov-2 pandemic, patients with immune-mediated inflammatory diseases (IMIDs) were faced with two pressing questions. Firstly, as these patients often use immunosuppressants, it was not known whether they would build sufficient immunity after a SARS-CoV-2 infection or vaccination. Secondly, IMID patients were concerned that vaccination could

AB - During the SARS-Cov-2 pandemic, patients with immune-mediated inflammatory diseases (IMIDs) were faced with two pressing questions. Firstly, as these patients often use immunosuppressants, it was not known whether they would build sufficient immunity after a SARS-CoV-2 infection or vaccination. Secondly, IMID patients were concerned that vaccination could

UR - https://pure.uva.nl/ws/files/174918489/Licentieovereenkomst_medeondertekend_.pdf

M3 - Phd-Thesis - Research and graduation internal

ER -

SARS-CoV-2 vaccination: Immunity and disease activity in immune- mediated inflammatory diseases

Abstract

Access to Document

Other files and links

Cite this